US equities
|
META
$624.77
▼-0.92%
TSLA
$405.93
▲+3.65%
MU
$932.60
▲+3.20%
NVDA
$218.70
▲+1.25%
SPCX
$150.99
▲+2.78%
AMD
$558.76
▲+5.17%
SNDK
$1,305.34
▲+3.96%
INTC
$94.07
▲+3.98%
META
$624.77
▼-0.92%
TSLA
$405.93
▲+3.65%
MU
$932.60
▲+3.20%
NVDA
$218.70
▲+1.25%
SPCX
$150.99
▲+2.78%
AMD
$558.76
▲+5.17%
SNDK
$1,305.34
▲+3.96%
INTC
$94.07
▲+3.98%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about Mitchell Kapoor
Recent news which mentions Mitchell Kapoor
Rain Oncology's Phase 3 Data Casts Doubt On Other Trials: Analyst Reevaluate Their Views
May 23, 2023
Tickers
RAIN
Tags
Graig Suvannavejh
Michael Schmidt
Market News
From
Benzinga